ACE2 and COVID-19: It might be possible that RAASi-induced upregulation of plasma ACE2 has a favourable effect on COVID-19 patients by improving arterial stiffness, lowering pulse wave velocity (PWV), and, therefore, lowering the risk for major adverse cardiac events.